BlueRock Therapeutics shall be offered on the 37th Annual Convention of JP Morgan Healthcare
CAMBRIDGE, Mass., January 2, 2019 / PRNewswire / – BlueRock Therapeutics, LP, a cell remedy firm designed Cell Gen + Platform for the event of regenerative medicines for intractable illnesses. Emile nuwaysir, President and CEO, will current on the 37th Annual Convention of JP Morgan Healthcare in Wednesday, January 9, 2019 have 10:30 a.m. PT / 1:30 p.m. Y on the Westin St. Francis resort in San Francisco.
A dwell broadcast will be accessed on the Firm's web site at www.bluerocktx.com. A replay of the webcast shall be out there after the occasion on the Firm's web site.
About BlueRock Therapeutics
BlueRock Therapeutics is a cell remedy firm designed with the intention of growing regenerative medicines for intractable illnesses. Bluerock's Cell Gen + Platform of neurology, cardiology and autoimmune indications. BlueRock cell differentiation expertise The biology of cell growth to provide native cell remedy, which is much more designed for an extra perform. Utilizing these cell therapies to switch broken or broken cells. BlueRock was based in 2016 by Versant Ventures and capitalized on one of many largest Sequence A financings in historical past by Bayer AG and Versant. The BlueRock tradition is outlined by scientific innovation, the very best moral requirements and the urgency of offering transformative remedies to all who would profit. For extra info go to www.bluerocktx.com.
David Schull gold Maggie Beller
Russo Companions, LLC
SOURCE BlueRock Therapeutics, LP